Cargando…

Genetic evidence for serum amyloid P component as a drug target for treatment of neurodegenerative disorders

The direct causes of neurodegeneration underlying Alzheimer’s disease (AD) and many other dementias, are not known. Here we identify serum amyloid P component (SAP), a constitutive plasma protein normally excluded from the brain, as a potential drug target. After meta-analysis of three genome-wide a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt, A Floriaan, Finan, Chris, Chopade, Sandesh, Ellmerich, Stephan, Rossor, Martin N, Hingorani, Aroon D, Pepys, Mark B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462209/ https://www.ncbi.nlm.nih.gov/pubmed/37645746 http://dx.doi.org/10.1101/2023.08.15.23293564

Ejemplares similares

Dementia in the older population is associated with neocortex content of serum amyloid P component
por: Ellmerich, Stephan, et al.
Publicado: (2021)

Genetic drug target validation using Mendelian randomisation
por: Schmidt, Amand F., et al.
Publicado: (2020)

Exploring the Role of Plasma Lipids and Statin Interventions on Multiple Sclerosis Risk and Severity: A Mendelian Randomization Study
por: Almramhi, Mona M., et al.
Publicado: (2023)

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits
por: Bodin, Karl, et al.
Publicado: (2010)

Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C‐reactive protein, for clinical use
por: Pepys, Mark B., et al.
Publicado: (2012)

Performance of polygenic risk scores in screening, prediction, and risk stratification: secondary analysis of data in the Polygenic Score Catalog
por: Hingorani, Aroon D, et al.
Publicado: (2023)

Improving the odds of drug development success through human genomics: modelling study
por: Hingorani, Aroon D., et al.
Publicado: (2019)

Lipid lowering and Alzheimer disease risk: A mendelian randomization study
por: Williams, Dylan M., et al.
Publicado: (2019)

Serum amyloid P component accumulates and persists in neurones following traumatic brain injury
por: Yip, Ping K., et al.
Publicado: (2023)

Interaction of serum amyloid P component with hexanoyl bis(d-proline) (CPHPC)
por: Kolstoe, Simon E., et al.
Publicado: (2014)

Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
por: Gordillo-Marañón, María, et al.
Publicado: (2021)

Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivo
por: Al-Shawi, Raya, et al.
Publicado: (2016)

LDL-C Concentrations and the 12-SNP LDL-C Score for Polygenic Hypercholesterolaemia in Self-Reported South Asian, Black and Caribbean Participants of the UK Biobank
por: Gratton, Jasmine, et al.
Publicado: (2022)

Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
por: Storm, Catherine S., et al.
Publicado: (2021)

Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component
por: DeBeer, FC, et al.
Publicado: (1981)

New therapeutic perspectives – amyloid removal
por: Pepys, Mark
Publicado: (2015)

Polygenic risk scores for coronary artery disease and subsequent event risk amongst established cases
por: Howe, Laurence J, et al.
Publicado: (2020)

Hydrogen sulfide, nitric oxide, and neurodegenerative disorders
por: Panthi, Sandesh, et al.
Publicado: (2018)

Adjustment for index event bias in genome-wide association studies of subsequent events
por: Dudbridge, Frank, et al.
Publicado: (2019)

Unexpected Inheritance of a Balanced Homologous translocation t(22q;22q) from father to a phenotypically normal daughter
por: Chopade, D. K., et al.
Publicado: (2014)

Genetic Variants at Chromosome 9p21 and Risk of First Versus Subsequent Coronary Heart Disease Events: A Systematic Review and Meta-Analysis
por: Patel, Riyaz S., et al.
Publicado: (2014)

Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1
por: Borthwick, Nicola J., et al.
Publicado: (2018)

Druggable proteins influencing cardiac structure and function: Implications for heart failure therapies and cancer cardiotoxicity
por: Schmidt, Amand F., et al.
Publicado: (2023)

Plasmin activity promotes amyloid deposition in a transgenic model of human transthyretin amyloidosis
por: Slamova, Ivana, et al.
Publicado: (2021)

Mendelian randomization for studying the effects of perturbing drug targets
por: Gill, Dipender, et al.
Publicado: (2021)

Imaging of aluminium and amyloid β in neurodegenerative disease
por: Exley, Christopher, et al.
Publicado: (2020)

The Paradoxical Effects of Serum Amyloid-P Component on Disseminated Candidiasis
por: Klotz, Stephen A., et al.
Publicado: (2022)

Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics
por: Giambartolomei, Claudia, et al.
Publicado: (2014)

What Are the Molecular Mechanisms by Which Functional Bacterial Amyloids Influence Amyloid Beta Deposition and Neuroinflammation in Neurodegenerative Disorders?
por: Friedland, Robert P., et al.
Publicado: (2020)

No Clinically Relevant Effect of Heart Rate Increase and Heart Rate Recovery During Exercise on Cardiovascular Disease: A Mendelian Randomization Analysis
por: Mensah-Kane, Josephine, et al.
Publicado: (2021)

Aggregation of Mouse Serum Amyloid A Protein Was Promoted by Amyloid-Enhancing Factors with the More Genetically Homologous Serum Amyloid A
por: Lin, Xuguang, et al.
Publicado: (2021)

Binding specificity of serum amyloid P component for the pyruvate acetal of galactose
Publicado: (1984)

Nucleosome binding by serum amyloid P component from SLE patients
por: Heegaard, NHH, et al.
Publicado: (2001)

Associations Between Measures of Sarcopenic Obesity and Risk of Cardiovascular Disease and Mortality: A Cohort Study and Mendelian Randomization Analysis Using the UK Biobank
por: Farmer, Ruth E., et al.
Publicado: (2019)

Editorial: The Biochemistry of Amyloids in Neurodegenerative Diseases, Volume I
por: Gomes, Cláudio M., et al.
Publicado: (2021)

HSP10 as a Chaperone for Neurodegenerative Amyloid Fibrils
por: Larsson, Johan N. K., et al.
Publicado: (2022)

Beyond amyloid: altered gene function in neurodegenerative diseases
por: Yesiltepe, Metin, et al.
Publicado: (2023)

Editorial: The biochemistry of amyloids in neurodegenerative diseases, volume II
por: Gomes, Cláudio M., et al.
Publicado: (2023)

Probability of encountering Covid-19 patients based on prevalence and testing during resumption of ophthalmology services
por: Keller, Johannes, et al.
Publicado: (2020)

Evaluation of Genetic Markers as Instruments for Mendelian Randomization Studies on Vitamin D
por: Berry, Diane J., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_cbd0ajf2kl2i6fm31jhsvtfg37